← Back to Search

Xanthine Oxidase Inhibitor

Allopurinol for Gout

Phase 4
Waitlist Available
Led By Jay B Higgs, MD
Research Sponsored by 59th Medical Wing
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pateints are assessed at five time intervals over 28 days: days 1, 3-4, 10-15, 20-25, and 28; day 28 reported
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions
Drug Has Already Been Approved
Pivotal Trial

Summary

This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.

Eligible Conditions
  • Gout

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pateints are assessed at five time intervals over 28 days: days 1, 3-4, 10-15, 20-25, and 28; day 28 reported
This trial's timeline: 3 weeks for screening, Varies for treatment, and pateints are assessed at five time intervals over 28 days: days 1, 3-4, 10-15, 20-25, and 28; day 28 reported for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Resolution of the Acute Gout Attack
Secondary study objectives
Pain Day 28
Physician Global Assessment of Gout Activity at Day 28
Serum Uric Acid Level

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: AllopurinolActive Control1 Intervention
Patients in this arm receive allopurinol, 100 mg daily for 14 days and then 200 mg daily for 14 days
Group II: Sugar pill (Placebo)Placebo Group1 Intervention
Patients in this arm receive one placebo (sugar) pill per day for 14 days then 2 placebo pills for 14 days.

Find a Location

Who is running the clinical trial?

59th Medical WingLead Sponsor
40 Previous Clinical Trials
12,615 Total Patients Enrolled
United States Air ForceFED
19 Previous Clinical Trials
52,146 Total Patients Enrolled
1 Trials studying Gout
100 Patients Enrolled for Gout
Jay B Higgs, MDPrincipal Investigator59th Medical Wing
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top